Activation of trk-A but not trk-B signal transduction pathway inhibits growth of neuroblastoma cells

E. Lucarelli, D. Kaplan, C. J. Thiele

Research output: Contribution to journalArticlepeer-review

Abstract

In neuroblastoma tumours, the expression of high levels of trk-A mRNA, which encodes the high-affinity nerve growth factor (NGF) receptor, is associated with good prognosis. Constitutive expression of brain-derived neurotrophic factor (BDNF) and variable expression of its receptor trk-H are frequently detected in tumours from patients with a poor prognosis. To evaluate the biological consequences of activation of the trk-A or trk-B signal transduction pathways in neuroblastoma cells, the trk-A or trk-B gene was transfected into the trk negative 15N neuroblastoma cell line. Clones expressing trk-A or trk-B were treated with specific ligands and evaluated for growth and differentiation. Both ligands induced neurite extension. Treatment of the 15N-trk-A clones with NGF inhibited proliferation (80-90% decrease), while treatment of the 15N-trk-B clone with BDNF had no effect (<10% decrease). NGF-induced growth inhibition was concentration dependent. Such studies indicate that differential trk expression may affect the biology of neuroblastoma tumours and contribute to differences in the clinical course of patients.

Original languageEnglish
Pages (from-to)2068-2070
Number of pages3
JournalEuropean Journal of Cancer
Volume33
Issue number12
DOIs
Publication statusPublished - Oct 1997

Keywords

  • BDNF
  • Neuroblastoma
  • NGF
  • trk-A
  • trk-B

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Activation of trk-A but not trk-B signal transduction pathway inhibits growth of neuroblastoma cells'. Together they form a unique fingerprint.

Cite this